HELIXOR M sol inj 100 mg 8 amp 2 ml
7680562070302
CH-56207
L01CX
20.02.
1 / 3
google
Details
- Product number
- 5620709
- CPT
- -
- Packaging group
- 8
- Unit
- Ampulle(n)
- Composition
- extractum aquosum liquidum 2 g ex viscum album (mali) recens 100 mg, natrii chloridum, aqua q.s. ad solutionem pro 2 ml.
Articles (1)
Helixor M 100 mg, Injektionslösung (s.c.)
Injektionslösung
8
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2012.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
6.48 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 98.85
Specialties list
Yes
Generic
No
SL addition date:
01/05/2008
Authorization holder
Target BioScience AG
8803 Rüschlikon
Authorization information
- Swissmedic authorization number
- 56207
- Drug name
- Helixor M, Injektionslösung (s.c.)
- Galenic form
- LSINJ
- ATC Code
- L01CX
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/09/2006
- Authorization expiration date
- 31/12/9999
- IT number
- 20.02.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HELIXOR M sol inj 100 mg 8 amp 2 ml
- Description (DE)
- HELIXOR M Inj Lös 100 mg 8 Amp 2 ml
- Market launch
- 08/09/2006
- Narcotic (BTM)
- No